Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting immunostaining in relation to complex human pathologies.TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding. Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
GRIN2C / NMDAR2C / NR2C is a subunit of the N-methyl-D-aspartate (NMDA) receptor, which is a subtype of ionotropic glutamate receptor. NMDA receptors are found in the central nervous system, are permeable to cations and have an important role in physiological processes such as learning, memory, and synaptic development. The receptor is a tetramer of different subunits (typically heterodimer of subunit 1 with one or more of subunits 2A-D), forming a channel that is permeable to calcium, potassium, and sodium, and whose properties are determined by subunit composition. Alterations in the subunit composition of the receptor are associated with pathophysiological conditions such as Parkinson's disease, Alzheimer's disease, depression, and schizophrenia. Alternative splicing results in multiple transcript variants.
|Gene Name:||glutamate receptor, ionotropic, N-methyl D-aspartate 2C|
|Family/Subfamily:||Ion Channel , Glutamate receptor - ionotropic (NMDA receptor)|
|Synonyms:||GRIN2C, GluN2C, NMDA receptor 2C, NMDAR2C, NR2C, GluR epsilon 3|
|Target Sequences:||NM_000835 NP_000826.2 Q14957|
If you do not find the reagent or information you require, please contact email@example.com to inquire about additional products in development.